Skip to content

The effect of concurrent use of swaddle and sucrose taste on the Intensity of pain During Venous Blood sampling in Neonate: A clinical trial Study

The effect of concurrent use of swaddle and sucrose taste on the Intensity of pain During Venous Blood sampling in Neonate: A clinical trial Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200913048704N2
Enrollment
60
Registered
2021-07-13
Start date
2021-08-03
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensity of pain During Venous Blood sampling in Preterm Neonates.

Interventions

Intervention 1: Intervention group: Sucrose group: Infants who receive 24%sucrose from 2 minutes before injection to 2 minutes after injection. In this group, the standard 24%sucrose, 0/2 ml / kg is

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 28 Days

Inclusion criteria

Inclusion criteria: Term infants with a gestational age of 42-37 weeks Stability of vital signs before sampling No congenital or genetic abnormalities Non-use of drugs, antidepressants and anticonvulsants by the mother during pregnancy No surgery and receiving anesthesia and anesthesia drugs Lack of intubation

Exclusion criteria

Exclusion criteria: Abnormalities in the head and skull such as cleft lip and palate and atrial fibrillation Infants who experience more than grade II intraventricular hemorrhage during the study.

Design outcomes

Primary

MeasureTime frame
Intensity of pain during venous blood sampling in preterm infants. Timepoint: 2 minutes before, during and 2 minutes after blood sampling. Method of measurement: Neonatal Infant Pain Scale.

Secondary

MeasureTime frame
Infant heart rate changes 15 minutes before, during and 15 minutes after intravenous sampling. Timepoint: 2 minutes before, during and 2 minutes after intravenous sampling. Method of measurement: Cardiorespiratory monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Zabihi

Babol University of Medical Sciences

zabihi_alii@yahoo.com+98 11 3219 0595

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026